Toby Eyre, MD

Articles by Toby Eyre, MD

Toby Eyre, MD, on the Future of BTK Inhibitors in CLL

Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | December 14, 2023

The debate on the future of Bruton's tyrosine kinase (BTK) inhibitors in CLL.